[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
March 30, 1935


Author Affiliations

Adjunct Dermatologist, Mount Sinai Hospital; Hematologist and Associate in Medicine, Mount Sinai Hospital NEW YORK
From the Medical Department and Laboratories, Mount Sinai Hospital.

JAMA. 1935;104(13):1066-1070. doi:10.1001/jama.1935.02760130016005

This report concerns the control of various types of bleeding by means of subcutaneous injections of a snake venom. In our experience this method has proved superior to the other forms of treatment commonly employed in cases characterized by a hemorrhagic tendency other than hemophilia or thrombocytopenic purpura haemorrhagica.

In 1928, Shwartzman1 described a phenomenon of skin reactivity (local hemorrhagic necrosis) to bacterial filtrates, which was produced when intradermal injections of these filtrates were followed at a suitable interval by intravenous injections. In 1930, one of us (S. M. P.) attempted, unsuccessfully, to produce the Shwartzman phenomenon with fungous extracts and then to render the reaction site more sensitive to the hypothetical toxic substances in fungous cultures by previous local injections of a vascular poison, snake venom. This proved unsuccessful. In the course of experiments2 it was found that, if a period of from fourteen days to one